Drug Patents owned by Auxilium Pharms Llc

1. List of Testim drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7935690 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(2 months from now)

US8178518 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(2 months from now)

US7608606 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(2 months from now)

US7608608 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(2 months from now)

US7608610 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(2 months from now)

US8063029 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(2 months from now)

US7608605 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(2 months from now)

US7608607 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(2 months from now)

US7608609 AUXILIUM PHARMS LLC Pharmaceutical composition
Apr, 2023

(2 months from now)

US7320968 AUXILIUM PHARMS LLC Pharmaceutical composition
Jan, 2025

(1 year, 11 months from now)

Drugs and Companies using TESTOSTERONE ingredient

Market Authorisation Date: 31 October, 2002

Treatment: Method for administration of testosterone

Dosage: GEL;TRANSDERMAL

How can I launch a generic of TESTIM before it's patent expiration?
More Information on Dosage

TESTIM family patents

23

United States

3

Hong Kong

2

Korea, Republic of

2

Spain

2

Argentina

2

China

2

Iceland

2

European Union

1

Austria

1

Brazil

1

Australia

1

Poland

1

Malaysia

1

Lithuania

1

Saudi Arabia

1

Germany

1

Israel

1

Cyprus

1

Mexico

1

Japan

1

South Africa

1

Egypt

1

Latvia

1

EA

1

Norway

1

New Zealand

1

Canada

1

Taiwan, Province of China

1

Denmark

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in